Literature DB >> 20590539

Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire.

Gianluca Giannarini1, Francis X Keeley, Francesca Valent, Francesca Manassero, Andrea Mogorovich, Riccardo Autorino, Cesare Selli.   

Abstract

OBJECTIVE: To assess the predictors of morbidity in patients with indwelling ureteric stents using a validated questionnaire. PATIENTS AND METHODS: Eighty-six consecutive patients with indwelling double-J ureteric stent of different length and size enrolled at an Italian tertiary academic centre were prospectively evaluated with the Italian-validated Ureteric Stent Symptoms Questionnaire (USSQ), which explores the stent-related symptoms in six domains. Ureteric stents were placed for benign ureteric obstruction or after uncomplicated ureterorenoscopy, and were all removed after 28 days. The questionnaire was administered on days 7 and 28 after stent placement and on day 28 after removal. A plain abdominal X-ray was performed on days 7 and 28 after placement to determine stent location. Univariable and multivariable analyses tested the association of patient age, sex and body mass index (BMI), and stent side, length, calibre and distal loop location, with the index score of the various domains on days 7 and 28.
RESULTS: All patients completed the study. At multivariable analysis, on day 7, sex, BMI and stent calibre were significantly associated with one domain (general health, body pain and work performance, respectively), while location of stent distal loop was significantly associated with five domains (urinary symptoms, body pain, general health, work performanc, and sexual matters). On day 28, body mass index was significantly associated with two domains (body pain and general health), while location of stent distal loop remained significantly associated with the same five domains (urinary symptoms, body pain, general health, work performance and sexual matters).
CONCLUSION: Location of stent distal loop with respect to midline had the strongest association with most domains of the USSQ on both days 7 and 28 after stent placement. The visualization of stent distal loop crossing the midline may therefore identify patients at higher risk of post-procedural morbidity requiring early management.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 20590539     DOI: 10.1111/j.1464-410X.2010.09482.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  31 in total

Review 1.  Ureteral stent-associated complications--where we are and where we are going.

Authors:  Dirk Lange; Samir Bidnur; Nathan Hoag; Ben H Chew
Journal:  Nat Rev Urol       Date:  2014-12-23       Impact factor: 14.432

Review 2.  The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.

Authors:  Jue Wang; Xiaobei Zhang; Tiande Zhang; Jianjun Mu; Bing Bai; Yi Lei
Journal:  World J Urol       Date:  2017-05-26       Impact factor: 4.226

3.  Development and evaluation of a centralised computerised registry for ureteric stents: completing the audit cycle.

Authors:  N F Davis; G Murray; T O'Connor; C Browne; E MacCraith; D Galvin; D Mulvin; D Quinlan; G Lennon
Journal:  Ir J Med Sci       Date:  2017-02-02       Impact factor: 1.568

4.  Intravesical stent position as a predictor of quality of life in patients with indwelling ureteral stent.

Authors:  Fam Xeng Inn; Nurzarina Ahmed; Loo Guo Hou; Zainal Adwin Zainal Abidin; Lim Li Yi; Zulkifli Md Zainuddin
Journal:  Int Urol Nephrol       Date:  2019-08-22       Impact factor: 2.370

Review 5.  Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction.

Authors:  Linda Hsu; Hanhan Li; Daniel Pucheril; Moritz Hansen; Raymond Littleton; James Peabody; Jesse Sammon
Journal:  World J Nephrol       Date:  2016-03-06

6.  Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.

Authors:  Kao-Lang Liu; Bo-Ching Lee; Jian-De Ye; Yu-Hsuan Chang; Chin-Chen Chang; Kuo-How Huang; Yuan-Ju Lee; Yeun-Chung Chang
Journal:  Eur Radiol       Date:  2018-07-04       Impact factor: 5.315

Review 7.  [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].

Authors:  C Netsch; B Becker; A J Gross
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

Review 8.  Ureteral Stent Discomfort and Its Management.

Authors:  Katherine M Fischer; Michael Louie; Phillip Mucksavage
Journal:  Curr Urol Rep       Date:  2018-06-11       Impact factor: 3.092

9.  Insertion of a single double-J stent for bilateral open ureteral reimplantation: introducing a novel technique and assessment of feasibility.

Authors:  Behnam Nabavizadeh; Sorena Keihani; Seyed Hossein Hosseini Sharifi; Abdol-Mohammad Kajbafzadeh
Journal:  Int Urol Nephrol       Date:  2016-04-04       Impact factor: 2.370

10.  Pilot Study to Determine Optimal Stent Duration Following Ureteroscopy: Three versus Seven days.

Authors:  Charles J Paul; Nathan A Brooks; George M Ghareeb; Chad R Tracy
Journal:  Curr Urol       Date:  2017-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.